Pinned Tweet
The 2025 IR Residency Practicum is happening June 5–7 in Chicago!
This 2.5-day event is designed to help graduating residents prepare for life in both academic and private practice settings.
Register by May 1 to take advantage of early bird rates: sirweb.org/learn/events/sir-…
UChicagoIR retweeted
Scenes from Day 1 of the 2025 SIR IR Residency Practicum #SIR25RP is in the books! @SIRspecialists Congrats to our residents who will transition from the @SIRRFS to @SIR_ECS
Kylie Zane MD (PGY4) awarded Society of Interventional Radiology RFS Clinical Advancement Award
#SIR25NASH @UChicagoIR @UChicagoRADS @SIRspecialists
Congrats Kylie!
UChicagoIR retweeted
A dream come true😭😭 @UChicagoIR I am so excited to join the best team!!!
UChicagoIR retweeted
Thank you for all your hard work @LukeWilkins_UVA and @rnavuluri! (Plus a shout out from one SIR staff member to another @JoyatSIR! Fantastic job! #SIR24RP
Incredibly proud of @SIRspecialists Spring Practicum leaders @LukeWilkins_UVA and @rnavuluri and all of the faculty volunteers and SIR staff for organizing an exceptional program!! @SIRRFS @SIR_ECS @theAPDIR
UChicagoIR retweeted
Incredibly proud of @SIRspecialists Spring Practicum leaders @LukeWilkins_UVA and @rnavuluri and all of the faculty volunteers and SIR staff for organizing an exceptional program!! @SIRRFS @SIR_ECS @theAPDIR
UChicagoIR retweeted
Day 2 of the IR Residency Practicum is in the books! Closing with the 2nd annual #SIR24RP trivia contest won by Team BSCU. Team Faculty is 0-2. Congrats to all!
UChicagoIR retweeted
Welcome to the residents, exhibitors and faculty of the @SIRspecialists 2024 IR Residency Practicum, led by course directors Dr. Luke Wilkins and Dr. Rakesh Navuluri @LukeWilkins_UVA @rnavuluri #SIR24RP
UChicagoIR retweeted
2024 IR Residency Practicum - Chicago, IL
Registration still open! sirweb.org/learning-center/m…
@SIRRFS @SIRspecialists
@LukeWilkins_UVA @rnavuluri @kmadass @VIRkhaja @MattHawkinsMD @MattScheidtVIR @saherssabri
@SamMouli @TheRealDoctorOs @Fritz_Angle @mikinvpatel @DivyaKumariMD @AhsunR @kush_r_desai @paragpatel_IR @arslanmd @sb_white1 @MattHawkinsMD @JTassMD @ir_huber
UChicagoIR retweeted
Join me, @rnavuluri, @kmadass, @VIRkhaja, @MattHawkinsMD, @MattScheidtVIR, @saherssabri, @SamMouli, @TheRealDoctorOs, @johnsmirnMD, @Fritz_Angle, Bob Lewandowski, Chuck Ray, Sarah White, and many others!!
Register here:
sirweb.org/learning-center/m…
UChicagoIR retweeted
The 2024 IR Residency Practicum program is now live! View the details of the in-person event and see how you can jump-start your career in IR. Topics include:
• Business of IR
• Procedural insights
• New devices/techniques
• Much more
sirweb.link/IRPprogram
Stupendous! @EndovasClarkY 🫡👏
After the initial submission ~20 months ago, we finally found a home for this paper 🥳🥳 Nothing is impossible with the dream team🙌🙌 @Subhash_Gutti @d_iyer7 @mikinvpatel @rnavuluri @TheRealDoctorOs
UChicagoIR retweeted
To say we are proud of @EndovasClarkY would be an understatement. It is an absolute joy to watch your star rise. 🫡
#SIR24SLC @SIRspecialists @SIRRFS @JVIRmedia @UChicagoIR
To say we are proud of @EndovasClarkY would be an understatement. It is an absolute joy to watch your star rise. 🫡
#SIR24SLC @SIRspecialists @SIRRFS @JVIRmedia @UChicagoIR
UChicagoIR retweeted
🌟 Wrapping up our Abstracts of the Year series by unveiling the 4th and final "Abstract of the Year" from the @SIRspecialists 2024 Conference, now in @JVIRmedia!
All 4 abstracts will be part of the Wednesday March 27th Plenary at SIR2024! Make sure to attend to get the full scoop! #SIR24SLC #SIR2024
Abstract 4 of 4 :
"Twenty Years of Radiofrequency Ablation for Intrahepatic Cholangiocarcinoma: A Population Study" offers key insights into cancer treatment. 🌟🔬🏥
🎯 Study Purpose:
Examining the effectiveness and survival trends of thermoablation in treating intrahepatic cholangiocarcinoma (iCCA) over two decades, using data from the SEER database. A crucial look into evolving cancer treatment methods! 🏥📊
🔍 Study Details:
❍ Data Source: SEER database, 2000-2020
❍ Patients Analyzed: 192 with iCCA
❍ Measures: Overall Survival (OS), with subgroup analysis based on various demographics and tumor characteristics
📊 Key Findings:
❍ Median Overall Survival (mOS): 28 months (95% CI: 22-32 months)
❍ Survival Rates: 1-yr OS 79.3%, 3-yr OS 35.8%, 5-yr OS 19.8%
❍ Improved Survival in Post-2010 Diagnoses (mOS: 32 vs. 21 months)
mOS by Disease Stage: Local 37 months, Regional 40 months, Distant 13 months
❍ Tumor Size Impact: ≤3 cm with mOS of 46 months, 3-5 cm with 32 months, >5 cm with 23 months
📌 Conclusion: Thermoablation for iCCA shows significant improvement in patient outcomes, particularly for those diagnosed after 2010 and with smaller tumor sizes. A huge discovery in iCCA management.
Thanks to @EndovasClarkY, @TheRealDoctorOs and colleagues for this impactful research! 🙏 @UChicagoIR
What potential do you see for thermoablation in iCCA treatment?
🌐 That concludes our series on the "Abstracts of the Year" from the @SIRspecialists 2024 Conference, as featured in @JVIRmedia! Congratulation to all the authors and thank you for your hard work!
📣 Follow us for more updates and subscribe to our newsletter for the latest in Vascular & Interventional Radiology: iradpulse.beehiiv.com/subscr…
#LiverCancer #RadiofrequencyAblation #Oncology #MedEd #PatientCare #MedicalResearch #Healthcare 🎗️🔍👩⚕️🩺🏥
UChicagoIR retweeted
Expert panel in medical liability: something that every IR should know Salt Palace Convention Center 355F @rnavuluri @DivyaKumariMD @UChicagoIR @UChicagoRADS #SIR24SLC
UChicagoIR retweeted
Amazing presentation on adrenal vein sampling from our incoming IR resident Anmol Patel! 👏👏We are excited to have her joining us!🎉🎉 @hilborn66 Zoe Miller @UMiamiHealth @UMMSM_IRIG @umiamimedicine @UChicagoIR @SIRRFS #SIR24SLC
UChicagoIR retweeted
Splenic Embolization by our incoming superstar IR resident! We are excited to have her🥳🥳@yee_erika @shamaryoungmd @ArizonaVIR @UChicagoIR #SIR24SLC @SIRRFS
UChicagoIR retweeted
Presenting 20-year experience of radiofrequency ablation for intrahepatic cholangiocarcinoma, Qian Yu states “ablation is effective but be careful with candidate selection”
Their results show patients with local disease and tumours <3 cm had superior survival outcomes #SIR24SLC









































